398 related articles for article (PubMed ID: 5598796)
1. [Features of the course and disorders of copper and ceruloplasmin metabolism in hepatolenticular degeneration].
Davidenkova EF; Neĭfakh SA; Butomo IV; Mashkov BA; Lapchenkov VI
Zh Nevropatol Psikhiatr Im S S Korsakova; 1967; 67(7):982-90. PubMed ID: 5598796
[No Abstract] [Full Text] [Related]
2. Evolution of the hepatic lesion in Wilson's disease (hepatolenticular degeneration).
Sternlieb I
Prog Liver Dis; 1972; 4():511-25. PubMed ID: 4569009
[No Abstract] [Full Text] [Related]
3. Observations on copper metabolism in Wilson's disease.
Czlonkowska A; Galewicz A; Rodo M; Wehr H
Acta Univ Carol Med Monogr; 1973; 56():175-7. PubMed ID: 4791768
[No Abstract] [Full Text] [Related]
4. [Kinetics of radioactive copper in Wilson's disease].
Willvonseder R; Goldstein NP; Tauxe WN
Wien Z Inn Med; 1973; 54(5):226-33. PubMed ID: 4790777
[No Abstract] [Full Text] [Related]
5. Incorporation of radiocopper into ceruloplasmin in normal subjects and in patients with primary biliary cirrhosis and Wilson's disease.
Vierling JM; Shrager R; Rumble WF; Aamodt R; Berman MD; Jones EA
Gastroenterology; 1978 Apr; 74(4):652-60. PubMed ID: 631501
[No Abstract] [Full Text] [Related]
6. Determination of liver enzymes, serum ceruloplasmin and urine copper in parents of children with Wilson's disease.
Haghighat M; Dehghani SM; Imanieh MH; Gholami S
Saudi Med J; 2008 Jul; 29(7):1056-7. PubMed ID: 18626543
[No Abstract] [Full Text] [Related]
7. [Copper and its compounds in physiological and pathological conditions].
Pawlak J
Wiad Lek; 1975 Jun; 28(11):949-52. PubMed ID: 1136458
[No Abstract] [Full Text] [Related]
8. [Proceedings: Differentiation of homozygote and heterozygote, therapy and follow-up study in 4 families with Wilson's disease].
Abendschein Th; Przuntek H; Wesch H; Gäng V
MMW Munch Med Wochenschr; 1975 May; 117(20):842. PubMed ID: 805973
[No Abstract] [Full Text] [Related]
9. Abnormalities of the physiology of copper in Wilson's disease. I. The whole-body turnover of copper.
O'Reilly S; Strickland GT; Weber PM; Beckner WM; Shipley L
Arch Neurol; 1971 May; 24(5):385-90. PubMed ID: 5554862
[No Abstract] [Full Text] [Related]
10. Study of copper metabolism in kinky hair disease (Menkes' disease) and in hepatolenticular degeneration (Wilson's disease) utilizing 67Cu and radioactivity counting in the total body and various tissues.
Dekaban AS; O'Reilly S; Aamodt R; Rumble WF
Trans Am Neurol Assoc; 1974; 99():106-9. PubMed ID: 4219083
[No Abstract] [Full Text] [Related]
11. [Metabolism of ceruloplasmin and copper in the blood in Wilson's disease].
Kanai M; Nomoto S; Tsukagoshi H; Shindo M
Rinsho Byori; 1974 Oct; 22(10 Suppl):191. PubMed ID: 4475793
[No Abstract] [Full Text] [Related]
12. [Pathobiochemistry of Wilson's disease].
Biesold D; Lössner J; Bachmann H; Zotter J
Z Med Lab Diagn; 1982 Oct; 23(5):278-84. PubMed ID: 7180077
[No Abstract] [Full Text] [Related]
13. Serum ceruloplasmin in hepatobiliary and other disorders: significance of abnormal values.
Gault MH; Stein J; Aronoff A
Gastroenterology; 1966 Jan; 50(1):8-18. PubMed ID: 5900960
[No Abstract] [Full Text] [Related]
14. Turnover studies of copper in homozygotes and heterozygotes for Wilson's disease and controls: isotope tracer studies with 67 Cu.
Strickland GT; Beckner WM; Leu ML; O'Reilly S
Clin Sci; 1972 Nov; 43(5):605-15. PubMed ID: 5083936
[No Abstract] [Full Text] [Related]
15. Further investigations on ceruloplasmin in hepatolenticular degeneration and on the effect of copper on oxidase activity of ceruloplasmin.
Wald I; Galewicz A; Górska D
Pol Med J; 1972; 11(3):733-9. PubMed ID: 5047986
[No Abstract] [Full Text] [Related]
16. [Iron and copper metabolism in hemochromatosis and Wilson's disease. Studies on relatives of patients].
Petera V; Lahn V; Virt S; Voleníková L; Kohout J
Z Gesamte Inn Med; 1969 May; 24(10):315-9. PubMed ID: 5807434
[No Abstract] [Full Text] [Related]
17. Failure of copper incorporation into ceruloplasmin in the Golgi apparatus of LEC rat hepatocytes.
Murata Y; Yamakawa E; Iizuka T; Kodama H; Abe T; Seki Y; Kodama M
Biochem Biophys Res Commun; 1995 Apr; 209(1):349-55. PubMed ID: 7726856
[TBL] [Abstract][Full Text] [Related]
18. Detection of the heterozygote of Wilson's disease.
O'Reilly S; Weber P; Pollycove M; Shipley L
J Nucl Med; 1969 Mar; 10(3):143-4. PubMed ID: 5785018
[No Abstract] [Full Text] [Related]
19. [The onset of psychiatric disorders and Wilson's disease].
Benhamla T; Tirouche YD; Abaoub-Germain A; Theodore F
Encephale; 2007 Dec; 33(6):924-32. PubMed ID: 18789784
[TBL] [Abstract][Full Text] [Related]
20. Wilson's disease patients with normal ceruloplasmin levels.
Yüce A; Koçak N; Ozen H; Gürakan F
Turk J Pediatr; 1999; 41(1):99-102. PubMed ID: 10770682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
